GI CANCERS

Clinical trials for GI CANCERS explained in plain language.

Never miss a new study

Get alerted when new GI CANCERS trials appear

Sign up with your email to follow new studies for GI CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 2

Experimental cancer drug enters human testing for Tough-to-Treat GI tumors

Disease control Recruiting now

This is the first study in US patients testing an experimental drug called 7MW4911 for advanced gastrointestinal cancers that have stopped responding to standard treatments. The research aims to find the safest and most effective dose while checking if the drug helps shrink tumor…

Matched conditions: GI CANCERS

Phase: PHASE1, PHASE2 • Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

GI CANCERS

Get alerted when new GI CANCERS trials appear

Experimental cancer drug enters human testing for Tough-to-Treat GI tumors